semaglutide bowel obstruction legal team in kentucky gastrointestinal law office glp-1 gastrointestinal obstruction law office kentucky Ozempic GLP-1 Lawsuit & Gastroparesis semaglutide gastric intestinal obstruction legal

5 December 2017

The oral options now also include the Wegovy pill , higher-dose oral semaglutide (up to a 25 mg maintenance dose) that the MHRA approved on 11 June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management

The Food and Drug Administration has also approved Wegovy as a treatment for heart disease, and Ozempic as a treatment to reduce risks of chronic kidney disease

Higher doses should be short-term and taken under professional guidance

For example, Wegovy (semaglutide) Typical Dosing Both weight loss medications are given as weekly injectable doses, but their dosage amounts differ

Wegovy is FDA-approved specifically for chronic weight management in adults with obesity or those who are overweight with weight-related conditions such as high blood pressure or type 2 diabetes